Cardiovascular therapeutics : a companion to Braunwald's by Elliott M. Antman MD

By Elliott M. Antman MD

Manage cardiovascular difficulties extra effectively with the main complete source to be had! A depended on significant other to Braunwald's center Disease, Cardiovascular Therapeutics, 4th Edition addresses pharmacological, interventional, and surgical administration methods for every form of heart problems. This functional and clinically concentrated cardiology reference deals a balanced, whole method of all the ordinary and strange parts of heart problems and particular remedies in a single concise quantity, equipping you to make the simplest offerings for each patient.

  • Understand present techniques to treating and dealing with cardiovascular patients
  • for long term health and wellbeing, for advanced difficulties, and for strange cardiac events.

  • Benefit from the vast adventure of Elliott M. Antman, MD, Marc S. Sabatine, MD, and a bunch of different revered professionals, who offer functional, evidence-based rationales for all of brand new scientific therapies.
  • Expand your wisdom past pharmacologic interventions with entire insurance of the simplest interventional and equipment cures getting used today.
  • Easily reference Braunwald's center ailment, ninth Edition for extra details on themes of interest.

  • Make the easiest use of the newest genetic and molecular therapies
  • in addition to advanced remedies for center failure.

  • Cut correct to the solutions you wish with an stronger concentrate on clinically proper details and a lowered emphasis on pathophysiology.
  • Stay present with ACC/AHA/ESC guidelines and the simplest how one can enforce them in scientific practice.
  • Get an more advantageous visible perspective with an all-new, full-color layout throughout.
  • Access the entire contents online and download images at www.expertconsult.com.

Show description

Read or Download Cardiovascular therapeutics : a companion to Braunwald's Heart disease PDF

Similar cardiology books

Cardiac Reconstructions with Allograft Tissues

This guide is a guide meant for citizens at any degree in their event, together with cardiothoracic fellowship. it really is intended as a tenet to appreciate the pathophysiologic purpose of motion within the working room and extensive care unit. Emphasis is put on body structure, anatomy, pathology, scientific administration, and surgical approach.

Grossman's Cardiac Catheterization, Angiography, and Intervention

Harvard scientific institution, Boston, MA. Brandon/Hill scientific checklist first-purchase choice (#58). scientific reference on invasive cardiology, for citizens and practitioners. complete textual content is contained on CD-ROM, that is on hand with the go back of enclosed card.

Cardiac Transplantation (Contemporary Cardiology)

Top physicians summarize during this easy-to-use and eminently functional guide the daily administration of transplant donors and recipients at Columbia-Presbyterian clinical middle. subject matters coated diversity from surgical ideas, pathology, and immunosuppression, to posttransplant administration, pediatric center transplantation, surgical possible choices, and mechanical circulatory information as a bridge to transplantation.

Perfusion for Congenital Heart Surgery: Notes on Cardiopulmonary Bypass for a Complex Patient Population

* hopefully devise a secure and winning plan for the pump run for sufferers present process surgical procedure for congenital center sickness. This functional consultant for perfusionists and different participants of the cardiac surgical crew offers details at the units, expertise and strategies required for winning skip of sufferers with congenital center defects * a realistic, spiral-bound, go-to reference designed to respond to the main frequently-posed questions about skip for CHD, the surgical operation of that's frequently complex * specializes in the newest expertise and methods and offers transparent, matter-of-fact counsel in line with particular diagnoses * Written through a pro perfusionist who's co-chief and educator at one of many global s best little ones s hospitals * Spiral binding permits the publication to be laid flat for simple referral within the working room * A notes part following each one analysis allows readers so as to add establishment and/or surgeon-specific details to tailor a pass plan for every CHD lesion

Extra info for Cardiovascular therapeutics : a companion to Braunwald's Heart disease

Sample text

Giugliano RP, Llevadot J, Wilcox RG, et al: Geographic 29 30 Decision-Making and Therapeutic Strategies in Cardiovascular Medicine 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 41. 42. variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II. Eur Heart J 2001;22:1702-15. Ray WA, Stein CM: Reform of drug regulation—beyond an independent drug-safety board. N Engl J Med 2006;354: 194-201.

Mortgages, depreciation, and so on). 116 Average (or unit) costs are total costs divided by total units, whereas incremental costs are those incurred by adding one additional unit of service, such as a program or an option. For example, the hospital costs for 1000 cardiac catheterizations $ / QALY How to Read and Interpret a Meta-analysis Table 1–6 Add Night Call 150,000 Add Needed Lab 100,000 Add Redundant Lab 50,000 0 Dominant 50 100 150 200 250 300 350 400 Number of AMIs / YEAR Figure 1–16 Costs/quality-adjusted life year (QALY) of primary percutaneous transluminal coronary angioplasty (PTCA) versus thrombolysis in acute myocardial infarction (AMI), demonstrating the effect of adding emergency hospital services, hospital volume, and differences with the use of randomized clinical trials (RCTs) (efficacy) versus community-based observational (effectiveness) data assumptions.

New York, Springer, 1998. DeMets DL, Califf RM: Lessons learned from recent cardiovascular clinical trials: Part I. Circulation 2002;106: 746-51. Antman EM, DeMets D, Loscalzo J. Cyclooxygenase inhibition and cardiovascular risk. Circulation. 2005;112:759-70. Curfman GD, Morrissey S, Drazen JM: Expression of concern reaffirmed. N Engl J Med 2006;354:1193. De Angelis CD, Drazen JM, Frizelle FA, et al: Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors.

Download PDF sample

Rated 4.25 of 5 – based on 43 votes